Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman Sells 2,000 Shares

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Andrew D. Lipman sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $12.32, for a total transaction of $24,640.00. Following the sale, the director now owns 27,225 shares of the company’s stock, valued at $335,412. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Nu Skin Enterprises Stock Up 7.1 %

NYSE NUS opened at $13.76 on Thursday. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. Nu Skin Enterprises, Inc. has a 1-year low of $12.06 and a 1-year high of $41.50. The company has a 50 day moving average of $14.95 and a 200-day moving average of $17.71. The company has a market cap of $679.77 million, a price-to-earnings ratio of 76.42 and a beta of 1.09.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, February 14th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.08. The firm had revenue of $488.64 million for the quarter, compared to analysts’ expectations of $479.35 million. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. On average, equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.13 earnings per share for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Shareholders of record on Monday, February 26th were paid a dividend of $0.06 per share. The ex-dividend date was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.74%. Nu Skin Enterprises’s payout ratio is presently 133.34%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. DA Davidson cut their price objective on shares of Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 5th. StockNews.com downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. Four research analysts have rated the stock with a hold rating, According to MarketBeat, Nu Skin Enterprises has an average rating of “Hold” and an average target price of $23.67.

Institutional Trading of Nu Skin Enterprises

Several institutional investors have recently modified their holdings of the business. State Street Corp grew its stake in shares of Nu Skin Enterprises by 39.4% in the first quarter. State Street Corp now owns 10,296,735 shares of the company’s stock worth $404,765,000 after purchasing an additional 2,912,086 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Nu Skin Enterprises by 0.9% in the third quarter. Vanguard Group Inc. now owns 6,235,495 shares of the company’s stock worth $132,255,000 after purchasing an additional 53,638 shares during the last quarter. BlackRock Inc. grew its stake in shares of Nu Skin Enterprises by 0.5% in the first quarter. BlackRock Inc. now owns 5,791,181 shares of the company’s stock worth $277,281,000 after purchasing an additional 30,340 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Nu Skin Enterprises by 2.2% in the first quarter. Renaissance Technologies LLC now owns 2,670,996 shares of the company’s stock worth $127,887,000 after purchasing an additional 58,600 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Nu Skin Enterprises by 0.7% in the second quarter. Dimensional Fund Advisors LP now owns 2,109,202 shares of the company’s stock valued at $70,025,000 after buying an additional 14,193 shares during the period. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.